Project Details
| Status | Finished |
|---|---|
| Effective start/end date | 4/10/12 → 4/10/14 |
Funding
- Eli Lilly & Company: $5,468.86
Protocol No.: I1Q-MC-JDDJ; Phase 2 Randomized Study to Investigate the Efficacy and Safety of LY2495655 VersusPlacebo in Older Patents who fell recently and havemuscle weakness. The Study compound is Anti-Myostatin Antibody
- Volpi, Elena (PI)
Project: Other project